These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12617927)

  • 1. Cancer chemotherapy: a SN-38 (7-ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug MonoTherapy) strategy.
    Angenault S; Thirot S; Schmidt F; Monneret C; Pfeiffer B; Renard P
    Bioorg Med Chem Lett; 2003 Mar; 13(5):947-50. PubMed ID: 12617927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucuronides in anti-cancer therapy.
    Chen X; Wu B; Wang PG
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):139-50. PubMed ID: 12678908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular prodrug that provides the irinotecan (CPT-11) active-metabolite SN-38 with ultralong half-life, low C(max), and low glucuronide formation.
    Santi DV; Schneider EL; Ashley GW
    J Med Chem; 2014 Mar; 57(6):2303-14. PubMed ID: 24494988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
    Leu YL; Chen CS; Wu YJ; Chern JW
    J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation.
    Prijovich ZM; Burnouf PA; Chou HC; Huang PT; Chen KC; Cheng TL; Leu YL; Roffler SR
    Mol Pharm; 2016 Apr; 13(4):1242-50. PubMed ID: 26824303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT).
    Leu YL; Roffler SR; Chern JW
    J Med Chem; 1999 Sep; 42(18):3623-8. PubMed ID: 10479293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy.
    Legigan T; Clarhaut J; Renoux B; Tranoy-Opalinski I; Monvoisin A; Jayle C; Alsarraf J; Thomas M; Papot S
    Eur J Med Chem; 2013 Sep; 67():75-80. PubMed ID: 23845743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of beta-glucuronidase by natural glucuronides of kampo medicines using glucuronide of SN-38 (7-ethyl-10-hydroxycamptothecin) as a substrate.
    Narita M; Nagai E; Hagiwara H; Aburada M; Yokoi T; Kamataki T
    Xenobiotica; 1993 Jan; 23(1):5-10. PubMed ID: 8484262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) beta-glucuronide and beta-galactoside for application in selective prodrug chemotherapy.
    Thomas M; Rivault F; Tranoy-Opalinski I; Roche J; Gesson JP; Papot S
    Bioorg Med Chem Lett; 2007 Feb; 17(4):983-6. PubMed ID: 17157009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cyclopamine glucuronide prodrug with improved kinetics of drug release.
    Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S
    Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour activity and toxicity of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in mice.
    Prijovich ZM; Chen BM; Leu YL; Chern JW; Roffler SR
    Br J Cancer; 2002 May; 86(10):1634-8. PubMed ID: 12085215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular, Macromolecular, and Supramolecular Glucuronide Prodrugs: Lead Identified for Anticancer Prodrug Monotherapy.
    Jarlstad Olesen MT; Walther R; Poier PP; Dagnaes-Hansen F; Zelikin AN
    Angew Chem Int Ed Engl; 2020 May; 59(19):7390-7396. PubMed ID: 32073708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel 10-substituted-7-ethyl-10-hydroxycamptothecin (SN-38) prodrugs.
    Zhou M; Liu M; He X; Yu H; Wu D; Yao Y; Fan S; Zhang P; Shi W; Zhong B
    Molecules; 2014 Nov; 19(12):19718-31. PubMed ID: 25438082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus Vectors.
    Bernt KM; Steinwaerder DS; Ni S; Li ZY; Roffler SR; Lieber A
    Cancer Res; 2002 Nov; 62(21):6089-98. PubMed ID: 12414633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug Mono Therapy: synthesis and biological evaluation of an etoposide glucuronide-prodrug.
    Schmidt F; Monneret C
    Bioorg Med Chem; 2003 May; 11(10):2277-83. PubMed ID: 12713838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin.
    Prijovich ZM; Leu YL; Roffler SR
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):7-17. PubMed ID: 16983566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifunctional supramolecular prodrug vesicles constructed from a camptothecin derivative with a water-soluble pillar[5]arene for cancer diagnosis and therapy.
    Sun G; He Z; Hao M; Xu Z; Hu XY; Zhu JJ; Wang L
    Chem Commun (Camb); 2019 Sep; 55(73):10892-10895. PubMed ID: 31436766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G.
    Kodawara T; Higashi T; Negoro Y; Kamitani Y; Igarashi T; Watanabe K; Tsukamoto H; Yano R; Masada M; Iwasaki H; Nakamura T
    Basic Clin Pharmacol Toxicol; 2016 May; 118(5):333-7. PubMed ID: 26518357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of hypoxia-activated prodrugs of SN-38.
    Jin C; Zhang Q; Lu W
    Eur J Med Chem; 2017 May; 132():135-141. PubMed ID: 28350997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.